Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16722 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16134 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate |
2011-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d93d402ed6615be01efc2887a36e65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_548e9ceab28b933c3720248a90c9efb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_082201b64bb2374942c61cb16bc165a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83580fb1e014f6369e5685a34d981191 |
publicationDate |
2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2814386-C |
titleOfInvention |
Antigen delivery platforms |
abstract |
This disclosure provides platforms for delivery of herpes virus proteins to cells, particularly proteins that form complexes in vivo. In some embodiments these proteins and the complexes they form elicit potent neutralizing antibodies. Thus, presentation of herpes virus proteins using the disclosed platforms permits the generation of broad and potent immune responses useful for vaccine development. |
priorityDate |
2010-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |